Sonoma pharmaceuticals to present at the h.c. wainwright bioconnect 2021 virtual conference

Woodstock, ga.--(business wire)--sonoma pharmaceuticals, inc. (nasdaq: snoa), a global healthcare leader developing and producing stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that ceo amy trombly and cfo jerry dvonch will present at the h.c. wainwright bioconnect 2021 virtual conference taking place january 11-14, 2021. the presentation is available for on
SNOA Ratings Summary
SNOA Quant Ranking